Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G50765109 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
JATT Ventures II L.P.
13D/A
Amendment 1
|
23.1% |
9/18/2026
Event 4/20/2026
|
|
| JATT Ventures II L.P. | 23.1% | ||
| Someit Sidhu | 23.1% | ||
|
JATT Ventures II L.P.
13D
|
23.1% |
9/15/2026
Event 4/20/2026
|
|
| JATT Ventures II L.P. | 23.1% | ||
| Someit Sidhu | 23.1% | ||
|
Commodore Capital LP
13G/A
Amendment 1
|
0% |
8/14/2026
Event 6/30/2026
|
|
| Commodore Capital LP | 0% | ||
| Commodore Capital Master LP | 0% | ||
| Robert Egen Atkinson | 0% | ||
| Michael Kramarz | 0% | ||
|
Great Point Partners, LLC
13G/A
Amendment 1
|
6.2% |
8/14/2026
Event 6/30/2026
|
|
| Great Point Partners, LLC | 6.2% | ||
| Dr. Jeffrey R. Jay, M.D. | 6.2% | ||
| Ms. Lillian Nordahl | 6.2% | ||
|
Balyasny Asset Management L.P.
13G
|
6.2% |
8/14/2026
Event 6/30/2026
|
|
| Balyasny Asset Management L.P. | 6.2% | ||
| Bam GP LLC | 6.2% | ||
| Balyasny Asset Management Holdings LP | 6.2% | ||
| Dames GP LLC | 6.2% | ||
| Dmitry Balyasny | 6.2% | ||
|
ADAR1 Capital Management, LLC
13G
|
5.4% |
8/14/2026
Event 6/30/2026
|
|
| ADAR1 Capital Management, LLC | 5.4% | ||
| Daniel Schneeberger | 5.4% | ||
|
Atika Capital Management LLC
13G
|
5.1% |
8/14/2026
Event 6/30/2026
|
|
| Atika Capital Management LLC | 5.1% | ||
| Brad Farber | 5.1% | ||
| Janus Henderson Group Ltd. 13G | 6.2% |
8/13/2026
Event 6/30/2026
|
|
|
RA Capital Management, L.P.
13G
|
6.4% |
4/27/2026
Event 4/20/2026
|
|
| RA Capital Management, L.P. | 6.4% | ||
| Peter Kolchinsky | 6.4% | ||
| Rajeev Shah | 6.4% | ||
| RA Capital Healthcare Fund, L.P. | 6.4% | ||
|
Commodore Capital LP
13G
|
6.4% |
4/24/2026
Event 4/17/2026
|
|
| Commodore Capital LP | 6.4% | ||
| Commodore Capital Master LP | 6.4% | ||
| Robert Egen Atkinson | 6.4% | ||
| Michael Kramarz | 6.4% | ||
|
Great Point Partners, LLC
13G
|
6.4% |
4/24/2026
Event 4/17/2026
|
|
| Great Point Partners, LLC | 6.4% | ||
| Dr. Jeffrey R. Jay, M.D. | 6.4% | ||
| Ms. Lillian Nordahl | 6.4% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 26 | 5.66 M | $64.3 M |